The ALOIS study tracks the progression of Alzheimer’s Dementia over a two year period, from mild to advanced severity. Patients and their carers will undergo observational assessments and physical health monitoring every 6 months.
Patients who wish to participate must fit the following criteria:
· Mild – Moderate Alzheimer’s
· MMSE score between 10-26
· 50+ years of age living in the community
· Reliable study partner
· Literate in English
· Not participating in another trial for Alzheimer’s